Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 377-384

  Yuvaraj, Srinivasan ^a   Premkumar, Vummidi Gridhar ^a   Shanthi, Palanivel ^a   Vijayasarathy, Kothandaraman ^b   Gangadaran, Sitthu Govindaswamy Dinakaran ^b   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

^b Kilpauk Medical College   (India)

Author keywords

Antioxidants; Biochemical derangements; Breast cancer; Postmenopausal; Tamoxifen

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ANTIESTROGEN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; GAMMA GLUTAMYLTRANSFERASE; KANEKA Q10; LIPOPROTEIN LIPASE; NICOTINIC ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; POTASSIUM; RIBOFLAVIN; TAMOXIFEN; TAMOXIFEN CITRATE; UBIDECARENONE; UNCLASSIFIED DRUG; URIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD CHEMICAL ANALYSIS; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; NIACIN; POSTMENOPAUSE; RIBOFLAVIN; TAMOXIFEN; UBIQUINONE; VITAMIN B COMPLEX;

EID: 59449093767     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0012-7     Document Type: Article

References (55)

1. R Yancik 2005 Population aging and cancer: a cross-national concern Cancer J 11 437 441
2. T Saphner DC Tormey R Gray 1996 Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 14 2738 2746
3. AV Dalen KJ Heering V Barak 1996 Treatment response in metastatic breast cancer. A multicentre study comparint UICC criteria and tumour marker changes Breast 5 82 88
4. B Weigelt JL Peterse LJ van't Veer 2005 Breast cancer metastasis: markers and models Nat Rev Cancer 5 591 602
5. A Decensi P Maisonneuve N Rotmensz Italian Tamoxifen Study Group 2005 Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial Circulation 8 650 656
6. MM Cruz Silva VM Madeira LM Almeida JB Custodio 2007 Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis Toxicol In Vitro 15 615 622
7. S Yuvaraj VG Premkumar K Vijayasarathy SG Gangadaran P Sachdanandam 2007 Ameliorating effect of coenzyme Q(10), riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins Clin Biochem 40 623 628
8. S Yuvaraj VG Premkumar K Vijayasarathy SG Gangadaran P Sachdanandam 2008 Augmented antioxidant status in tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q(10), Niacin and Riboflavin Cancer Chemother Pharmacol 61 933 941
9. JW Adlard J Campbell JM Bishop DJ Dodwell 2002 Morbidity of tamoxifen-perceptions of patients and healthcare professionals Breast 11 335 339
10. IS Elefsiniotis KD Pantazis A Ilias 2004 Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance Eur J Gastroenterol Hepatol 16 593 598
11. M Baum AU Budzar J Cuzick ATAC Trialists' Group 2002 Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial Lancet 359 2131 2139
12. A Munshi P Singh 2007 Tamoxifen in breast cancer: not so easy to write off Breast 17 121 124
13. J Cuzick JF Forbes I Sestak International Breast Cancer Intervention Study I Investigators 2007 Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial J Natl Cancer Inst 99 272 282
14. H Nohl L Gille AV Kozlov 1999 Critical aspects of the antioxidant function of coenzyme Q in biomembranes Biofactors 9 155 161
15. A Yalcin E Kilinc A Sagcan H Kultursay 2007 Coenzyme Q10 concentrations in coronary artery disease Clin Biochem 37 706 709
16. VG Premkumar S Yuvaraj K Vijayasarathy SG Gangadaran P Sachdanandam 2007 Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy Biol Pharm Bull 30 367 370
17. Y Imada H Iida S Ono S Murahashi 2003 Flavin catalyzed oxidations of sulfides and amines with molecular oxygen J Am Chem Soc 125 2868 2869
18. J Pangrekar K Krishnaswamy V Jagadeesan 1993 Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding Food Chem Toxicol 31 745 750
19. M Van Den Donk B Buijsse SW Van den Berg 2005 Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study Cancer Epidemiol Biomarkers Prev 14 1562 1566
20. M Kimura K Umegaki M Higuchi P Thomas M Fenech 2004 Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes J Nutr 134 48 56
21. EL Jacobson PU Giacomoni MJ Roberts GT Wondrak MK Jacobson 2001 Optimizing the energy status of skin cells during solar radiation J Photochem Photobiol B 63 141 147
22. CA Benavente EL Jacobson 2008 Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes Free Radic Biol Med 44 527 537
23. SH Ganji VS Kamanna ML Kashyap 2003 Niacin and cholesterol: role in cardiovascular disease (Review) J Nutr Biochem 14 298 305
24. JT Dodge C Mitchell DJ Hanahan 1963 The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes Arch Biochem Biophys 100 119 130
25. Legraud A, Gulliansseav RJ, Land J (1979) Method colorimetric simple determination del'activit., de la lecithin cholesterol acyl transferase (LCAT) Plasmatique. Interest on diabeteologic. In: Siest G, Glateau MM (eds) Biologic prospective. Masson, Paris, pp 368-371
26. J Hitz J Steinmetz G Siest 1983 Plasma lecithin: cholesterol acyltransferase-reference values and effects of xenobiotics Clin Chim Acta 133 85 96
27. Riley C (1966) Flame photometers. A comparative list of IS instruments. Technical Bulletin, No. 8, Association of clinical Biochemistry. From Ireland JT, After Hey Children's Hospital, Liverpool
28. Bonting SL (1970) In: Bittar EE (ed) Membranes and ion transport. Wiley-Inter Science, London, pp 257-263
29. 2+-ATPase from erythrocyte membranes Biochim Biophys Acta 728 281 288
30. T Ohnishi T Suzuki Y Suzuki K Ozawa 1982 A comparative study of plasma membrane Mg2+-ATPase activities in normal, regenerating and malignant cells Biochim Biophys Acta 684 67 74
31. A Buzdar A Howell J Cuzick 2006 Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial Lancet Oncol 7 633 643
32. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717
33. C Lox C Ronaghan E Cobos 1998 Blood chemistry profile in menopausal women administered tamoxifen for breast cancer Gen Pharmacol 30 121 124
34. HA El-Beshbishy 2005 The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective J Biochem Mol Biol 38 300 306
35. L Mehreen A Khanam 2005 Evaluation of toxicities induced by chemotherapy in breast cancer patients Biomed Pharmacother 59 524 527
36. U Hellmann-Blumberg TL Taras GT Wurz MW DeGregorio 2000 Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene Breast Cancer Res Treat 60 63 67
37. HJ Powers 2003 Riboflavin (vitamin B-2) and health Am J Clin Nutr 77 352 1360
38. HJ Powers 1999 Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine Proc Nutr Soc 58 435 440
39. FL Crane 2007 Discovery of ubiquinone (coenzyme Q) and an overview of function Mitochondrion 7 2 7
40. LC López M Schuelke CM Quinzii 2006 Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations Am J Hum Genet 79 1125 1129
41. A Upaganlawar M Farswan S Rathod R Balaraman 2006 Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats Indian J Exp Biol 44 416 418
42. D Appenroth O Schulz K Winnefeld 1996 Riboflavin can decrease the nephrotoxic effect of chromate in young and adult rats Toxicol Lett 87 47 52
43. FA Hemieda 2007 Influence of gender on tamoxifen-induced biochemical changes in serum of rats Mol Cell Biochem 301 137 142
44. X Han JG Liehr 1992 Induction of covalent DNA adducts in rodents by tamoxifen Cancer Res 52 1360 1363
45. O Kovalchuk T Han JC Fuscoe SA Ross FA Beland 2007 Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis Toxicol Appl Pharmacol 225 61 69
46. SK Kamath JM Tang PO Bramante 1977 Effect of dietary ascorbic acid on serum lipids and lipoprotein lipase activity in adipose and cardiac tissue in the guinea pig Fed proc 36 114 120
47. K Kumar P Sachdanandam R Arivazhagan 1991 Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer Biochem Int 23 581 589
48. A Takagi Y Ikeda M Tsushima A Yamamoto 1997 Molecular and environmental base of primary type IV hyperlipoprotemia heterozygous lipoprotein lipase deficiency as a cause of genetic disorders Atherosclerosis 134 27 29
49. V Kagan E Serbinova L Packer 1990 Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling Biochem Biophys Res Commun 169 851 857
50. RR Love RB Mazess HS Barden 1992 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer N Engl J Med 326 852 856
51. Y Lomnicky M Friedman MH Luria I Raz A Hoffman 1998 The effect of the mode of administration on the hypolipidaemic activity of niacin: continuous gastrointestinal administration of low-dose niacin improves lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats J Pharm Pharmacol 50 1233 1239
52. FF Vincenzi 1971
53. MW Fariss GA Pascoe DJ Reed 1985 Vitamin E reversal of the effect of extracellular calcium on chemically induced toxicity in hepatocytes Science 227 751 754
54. GA Pascoe MW Fariss K Olafsdottir DJ Reed 1987 A role of vitamin E in protection against cell injury. Maintenance of intracellular glutathione precursors and biosynthesis Eur J Biochem 166 241 247
55. SS Perumal P Shanthi P Sachdanandam 2005 Energy-modulating vitamins-a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma Br J Nutr 93 901 909